Njardarson JT - Search Results

1

Analysis of US FDA-Approved Drugs Containing Sulfur Atoms.

Scott KA, Njardarson JT. Scott KA, et al. Among authors: njardarson jt. Top Curr Chem (Cham). 2018 Jan 22;376(1):5. doi: 10.1007/s41061-018-0184-5. Top Curr Chem (Cham). 2018. PMID: 29356979 Review.

2

Pharmaceutical structure montages as catalysts for design and discovery.

Njarðarson JT. Njarðarson JT. Future Med Chem. 2012 May;4(8):951-4. doi: 10.4155/fmc.12.30. Future Med Chem. 2012. PMID: 22650237

3

Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.

Ilardi EA, Vitaku E, Njardarson JT. Ilardi EA, et al. Among authors: njardarson jt. J Med Chem. 2014 Apr 10;57(7):2832-42. doi: 10.1021/jm401375q. Epub 2013 Oct 29. J Med Chem. 2014. PMID: 24102067

4

Beyond C, H, O, and N! Analysis of the elemental composition of U.S. FDA approved drug architectures.

Smith BR, Eastman CM, Njardarson JT. Smith BR, et al. Among authors: njardarson jt. J Med Chem. 2014 Dec 11;57(23):9764-73. doi: 10.1021/jm501105n. Epub 2014 Oct 6. J Med Chem. 2014. PMID: 25255063 Review.

5

Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals.

Vitaku E, Smith DT, Njardarson JT. Vitaku E, et al. Among authors: njardarson jt. J Med Chem. 2014 Dec 26;57(24):10257-74. doi: 10.1021/jm501100b. Epub 2014 Oct 7. J Med Chem. 2014. PMID: 25255204 Review.

6

New Class of Anion-Accelerated Amino-Cope Rearrangements as Gateway to Diverse Chiral Structures.

Chogii I, Das P, Fell JS, Scott KA, Crawford MN, Houk KN, Njardarson JT. Chogii I, et al. Among authors: njardarson jt. J Am Chem Soc. 2017 Sep 20;139(37):13141-13146. doi: 10.1021/jacs.7b07319. Epub 2017 Sep 8. J Am Chem Soc. 2017. PMID: 28885835

7

Correction to "New Class of Anion-Accelerated Amino-Cope Rearrangements as Gateway to Diverse Chiral Structures".

Chogii I, Das P, Fell JS, Scott KA, Crawford MN, Houk KN, Njardarson JT. Chogii I, et al. Among authors: njardarson jt. J Am Chem Soc. 2018 Jul 25;140(29):9314. doi: 10.1021/jacs.8b06895. Epub 2018 Jul 16. J Am Chem Soc. 2018. PMID: 30010325 No abstract available.

8

From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.

Delost MD, Smith DT, Anderson BJ, Njardarson JT. Delost MD, et al. Among authors: njardarson jt. J Med Chem. 2018 Dec 27;61(24):10996-11020. doi: 10.1021/acs.jmedchem.8b00876. Epub 2018 Aug 1. J Med Chem. 2018. PMID: 30024747 Review.

9

A Survey of the Structures of US FDA Approved Combination Drugs.

Das P, Delost MD, Qureshi MH, Smith DT, Njardarson JT. Das P, et al. Among authors: njardarson jt. J Med Chem. 2019 May 9;62(9):4265-4311. doi: 10.1021/acs.jmedchem.8b01610. Epub 2018 Nov 30. J Med Chem. 2019. PMID: 30444362 Review.

10

A Structural Analysis of the FDA Green Book-Approved Veterinary Drugs and Roles in Human Medicine.

Scott KA, Qureshi MH, Cox PB, Marshall CM, Bellaire BC, Wilcox M, Stuart BAR, Njardarson JT. Scott KA, et al. Among authors: njardarson jt. J Med Chem. 2020 Dec 24;63(24):15449-15482. doi: 10.1021/acs.jmedchem.0c01502. Epub 2020 Oct 30. J Med Chem. 2020. PMID: 33125236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters